Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

7:58 PM ET Form 4
Insider Selling Columbia Sportswear Co COLM

Columbia Sportswear President Peter J. Bragdon Sells $26.6K of Stock

Peter J. Bragdon, President, sold 375 shares of Columbia Sportswear Co at $70.81 a share, worth $26.6K in total on Nov 2, 2026. Shares held after the trade: 28,950 (-1.3%).

Value
$26.6K
Shares
375
Price
$70.81
Role
President
Holding change
-1.3%
Trade date
Nov 2, 2026
7:39 PM ET Form 4
Insider Selling Duolingo, Inc. DUOL

Duolingo Insider William B. Gordon Sells $1.36M of Stock

William B. Gordon sold 10,000 shares of Duolingo, Inc. at $132.14 to $139.20 a share (average $136.38) in 8 transactions, worth $1.36M in total on Nov 2, 2026. Shares held after the trade: 58,415 (-1.2%).

Value
$1.36M
Shares
10,000
Average price
$136.38
Holding change
-1.2%
Trade date
Nov 2, 2026
7:35 PM ET Form 4
Insider Selling Tango Therapeutics, Inc. TNGX

Tango Therapeutics President, R&D Adam Crystal Sells $112K of Stock

Adam Crystal, President, R&D, sold 5,000 shares of Tango Therapeutics, Inc. at $22.26 to $22.99 a share (average $22.42) in 2 transactions, worth $112K in total on Nov 2, 2026. Shares held after the trade: 115,743 (-0.9%).

Value
$112K
Shares
5,000
Average price
$22.42
Role
President, R&D
Holding change
-0.9%
Trade date
Nov 2, 2026
7:32 PM ET Form 4
Insider Selling Tango Therapeutics, Inc. TNGX

Tango Therapeutics Principal Accounting Officer Jessica Newcomb Sells $158K of Stock

Jessica Newcomb, Principal Accounting Officer, sold 7,031 shares of Tango Therapeutics, Inc. at $22.28 to $22.98 a share (average $22.42) in 2 transactions, worth $158K in total on Nov 2, 2026. Shares held after the trade: 52,090 (-2.7%).

Value
$158K
Shares
7,031
Average price
$22.42
Role
Principal Accounting Officer
Holding change
-2.7%
Trade date
Nov 2, 2026
7:32 PM ET Form 4
Insider Selling Old National Bancorp ONB

Old National Bancorp CFO John V. Moran Sells $493K of Stock

John V. Moran, CFO, sold 19,261 shares of Old National Bancorp at $25.57 a share, worth $493K in total on Nov 3, 2026. Shares held after the trade: 101,467 (-16.0%).

Value
$493K
Shares
19,261
Price
$25.57
Role
CFO
Holding change
-16.0%
Trade date
Nov 3, 2026
7:27 PM ET Form 4
Insider Selling Corcept Therapeutics Inc CORT

Corcept Therapeutics Insider Sean Maduck Sells $2.05M of Stock

Sean Maduck sold 25,000 shares of Corcept Therapeutics Inc at $81.42 to $82.68 a share (average $81.85) in 3 transactions, worth $2.05M in total between Nov 2, 2026 and Nov 3, 2026. Shares held after the trade: 9,938 (-31.4%).

Value
$2.05M
Shares
25,000
Average price
$81.85
Holding change
-31.4%
Trade date
Nov 2, 2026 to Nov 3, 2026
7:21 PM ET Form 4
Insider Selling Snowflake Inc. SNOW

Snowflake EVP, Product Management Christian Kleinerman Sells $3.06M of Stock

Christian Kleinerman, EVP, Product Management, sold 10,000 shares of Snowflake Inc. at $306.01 a share, worth $3.06M in total on Nov 2, 2026. Shares held after the trade: 303,738 (-3.2%).

Value
$3.06M
Shares
10,000
Price
$306.01
Role
EVP, Product Management
Holding change
-3.2%
Trade date
Nov 2, 2026
7:21 PM ET Form 4
Insider Selling Corcept Therapeutics Inc CORT

Corcept Therapeutics President, Oncology Roberto Wandenkolk Vieira Sells $674K of Stock

Roberto Wandenkolk Vieira, President, Oncology, sold 8,333 shares of Corcept Therapeutics Inc at $80.73 to $81.52 a share (average $80.89) in 2 transactions, worth $674K in total on Nov 2, 2026. Shares held after the trade: 3,946 (-29.8%).

Value
$674K
Shares
8,333
Average price
$80.89
Role
President, Oncology
Holding change
-29.8%
Trade date
Nov 2, 2026
7:13 PM ET Form 4
Insider Selling Accel Entertainment, Inc. ACEL

Accel Entertainment President and CEO Mark T. Phelan Sells $300K of Stock

Mark T. Phelan, President and CEO, sold 25,000 shares of Accel Entertainment, Inc. at $12.00 a share, worth $300K in total on Nov 2, 2026. Shares held after the trade: 216,464 (-10.4%).

Value
$300K
Shares
25,000
Price
$12.00
Role
President and CEO
Holding change
-10.4%
Trade date
Nov 2, 2026
7:13 PM ET Form 4
Insider Selling Tenable Holdings, Inc. TENB

Tenable Holdings Insider A. Brooke Seawell Sells $1.49M of Stock

A. Brooke Seawell sold 30,000 shares of Tenable Holdings, Inc. at $48.73 to $50.33 a share (average $49.53) in 2 transactions, worth $1.49M in total on Nov 2, 2026. Shares held after the trade: 0 (-100.0%).

Value
$1.49M
Shares
30,000
Average price
$49.53
Holding change
-100.0%
Trade date
Nov 2, 2026
7:13 PM ET Form 4
Insider Selling Tenable Holdings, Inc. TENB

Tenable Holdings Insider Barron Anschutz Sells $510K of Stock

Barron Anschutz sold 10,000 shares of Tenable Holdings, Inc. at $51.00 a share, worth $510K in total on Nov 2, 2026. Shares held after the trade: 66,077 (-13.1%).

Value
$510K
Shares
10,000
Price
$51.00
Holding change
-13.1%
Trade date
Nov 2, 2026
7:12 PM ET Form 4
Insider Selling Republic Services, Inc. RSG

Republic Services EVP, Chief Development Officer Brian A. Bales Sells $830K of Stock

Brian A. Bales, EVP, Chief Development Officer, sold 3,400 shares of Republic Services, Inc. at $244.00 a share, worth $830K in total on Nov 2, 2026. Shares held after the trade: 17,616 (-16.2%).

Value
$830K
Shares
3,400
Price
$244.00
Role
EVP, Chief Development Officer
Holding change
-16.2%
Trade date
Nov 2, 2026
6:48 PM ET Form 4
Insider Buying Aspen Neuroscience, Inc. ASPE

Aspen Neuroscience Insider Peter A. Thompson Buys $15M of Stock

Peter A. Thompson bought 1,000,000 shares of Aspen Neuroscience, Inc. at $15.00 a share, worth $15M in total on Nov 2, 2026. Shares held after the trade: 3,589,132 (+38.6%).

Value
$15M
Shares
1,000,000
Price
$15.00
Holding change
+38.6%
Trade date
Nov 2, 2026
6:43 PM ET Form 4
Insider Buying Aspen Neuroscience, Inc. ASPE

Aspen Neuroscience Insider Orbimed Advisors LLC Buys $15M of Stock

Orbimed Advisors LLC bought 1,000,000 shares of Aspen Neuroscience, Inc. at $15.00 a share, worth $15M in total on Nov 2, 2026. Shares held after the trade: 3,589,132 (+38.6%).

Value
$15M
Shares
1,000,000
Price
$15.00
Holding change
+38.6%
Trade date
Nov 2, 2026
6:41 PM ET Form 4
Insider Selling Rubrik, Inc. RBRK

Rubrik CTO Arvind Nithrakashyap Sells $4.51M of Stock

Arvind Nithrakashyap, CTO, sold 38,460 shares of Rubrik, Inc. at $114.17 to $122.42 a share (average $117.39) in 21 transactions, worth $4.51M in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 272,538 (-0.1%).

Value
$4.51M
Shares
38,460
Average price
$117.39
Role
CTO
Holding change
-0.1%
Trade date
Nov 2, 2026 to Nov 4, 2026
6:39 PM ET Form 4
Insider Selling Arcutis Biotherapeutics, Inc. ARQT

Arcutis Biotherapeutics EVP, CLO Masaru Matsuda Sells $1.41M of Stock

Masaru Matsuda, EVP, CLO, sold 41,219 shares of Arcutis Biotherapeutics, Inc. at $31.86 to $34.32 a share (average $34.24) in 2 transactions, worth $1.41M in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 111,289 (-26.4%).

Value
$1.41M
Shares
41,219
Average price
$34.24
Role
EVP, CLO
Holding change
-26.4%
Trade date
Nov 2, 2026 to Nov 4, 2026
6:39 PM ET Form 4
Insider Selling Arcutis Biotherapeutics, Inc. ARQT

Arcutis Biotherapeutics EVP, CMO Patrick Burnett Sells $30K of Stock

Patrick Burnett, EVP, CMO, sold 943 shares of Arcutis Biotherapeutics, Inc. at $31.86 a share, worth $30K in total on Nov 2, 2026. Shares held after the trade: 116,649 (-0.8%).

Value
$30K
Shares
943
Price
$31.86
Role
EVP, CMO
Holding change
-0.8%
Trade date
Nov 2, 2026
6:38 PM ET Form 4
Insider Selling Arcutis Biotherapeutics, Inc. ARQT

Arcutis Biotherapeutics Insider Todd Watanabe Sells $139K of Stock

Todd Watanabe sold 4,377 shares of Arcutis Biotherapeutics, Inc. at $31.86 a share, worth $139K in total on Nov 2, 2026. Shares held after the trade: 712,826 (-0.6%).

Value
$139K
Shares
4,377
Price
$31.86
Holding change
-0.6%
Trade date
Nov 2, 2026
6:36 PM ET Form 4
Insider Selling Meta Platforms, Inc. META

Meta Platforms COO Javier Olivan Sells $967K of Stock

Javier Olivan, COO, sold 1,575 shares of Meta Platforms, Inc. at $614.15 a share, worth $967K in total on Nov 2, 2026. Shares held after the trade: 74,989 (-0.5%).

Value
$967K
Shares
1,575
Average price
$614.15
Role
COO
Holding change
-0.5%
Trade date
Nov 2, 2026
6:35 PM ET Form 4
Insider Selling Jazz Pharmaceuticals plc JAZZ

Jazz Pharmaceuticals Insider Bruce C. Cozadd Sells $1.3M of Stock

Bruce C. Cozadd sold 6,000 shares of Jazz Pharmaceuticals plc at $215.84 a share, worth $1.3M in total on Nov 2, 2026. Shares held after the trade: 339,875 (-1.7%).

Value
$1.3M
Shares
6,000
Price
$215.84
Holding change
-1.7%
Trade date
Nov 2, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.